IEFM
QNTM

IQ EQ Fund Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

IQ EQ Fund Management’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,948
Closed -$1.01M – 269
2021
Q2 		$1.01M Buy
8,948
+2,240
+33% +$260K 0.15% 158
2021
Q1 		$833K Buy
+6,708
New +$938K 0.15% 160

Other funds holding QNTM

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
RM
Resource Management Metairie, Louisiana $970M AUM 28.05% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IQ EQ Fund Management's QNTM Position: Q3 2021 in Review

IQ EQ Fund Management sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2021, closing a stake of 8,948 shares — an estimated $1.01M sold.

IQ EQ Fund Management first reported a position in QNTM in Q1 2021 and held it in 2 quarters. The position peaked at $1.01M in Q2 2021. 17 funds tracked by Wall St. Rank hold QNTM as of Q3 2021.

  • IQ EQ Fund Management reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2021 after selling out during the quarter.
  • IQ EQ Fund Management sold 8,948 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2021, an estimated $1.01M.
  • IQ EQ Fund Management first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2021 and held it in 2 quarters.
  • IQ EQ Fund Management's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $1.01M in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2021.

Based on IQ EQ Fund Management's 13F filing for Q3 2021, filed 27 Oct 2021.